B of A Securities Maintains Buy on Insmed, Raises Price Target to $83
Insmed Incorporated +1.41% Pre
Insmed Incorporated INSM | 71.96 72.01 | +1.41% +0.07% Pre |
B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:
INSM) with a Buy and raises the price target from $62 to $83.